SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells

Oncogene

Volumn 22, Issue 16, 2003, Pages 2443-2451

  Bhattacharya, Sabyasachi ^a   Garriga, Judit ^a   Calbó, Joaquim ^a,b   Yong, Thomas ^a   Haines, Dale S ^a   Graña, Xavier ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Adenoviruses; CDK; Cyclin D1; Cyclin E; E2F1

Indexed keywords

CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN E; LACTACYSTIN; LIGASE; PROTEASOME INHIBITOR; PROTEIN; PROTEIN P130; PROTEIN SKP 2; UBIQUITIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DOSE RESPONSE; DOWN REGULATION; FIBROBLAST; HALF LIFE TIME; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

CELL CYCLE PROTEINS; CELL LINE; CYSTEINE ENDOPEPTIDASES; G1 PHASE; HUMANS; MULTIENZYME COMPLEXES; PEPTIDE SYNTHASES; PHOSPHOPROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; RETINOBLASTOMA-LIKE PROTEIN P130; S PHASE; S-PHASE KINASE-ASSOCIATED PROTEINS; SKP CULLIN F-BOX PROTEIN LIGASES; UBIQUITIN;

EID: 0038708117     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206339     Document Type: Article

References (43)

1. Adams PD, Sellers WR, Sharma SK, Wu AD, Nalin CM and Kaelin WG. (1996). Mol. Cell. Biol., 16, 6623-6633.
2. Ausubel FM, Brent R, Kington RE, Moore DD, Seidman JG, Smith JA and Struhl KE. (1988). Current Protocols in Molecular Biology Greene Publishing Associates and Wiley-Interscience: New York.
3. Calbó J, Parreño M, Sotillo E, Yong T, Mazo A, Garriga J and Graña X. (2002). J. Biol. Chem., 277, 50263-50274.
4. Carrano AC, Eytan E, Hershko A and Pagano M. (1999). Nat. Cell Biol., 1, 193-199.
5. Castano E, Kleyner Y and Dynlacht BD. (1998). Mol. Cell. Biol., 18, 5380-5391.
6. Cheng L, Rossi F, Fang W, Mori T and Cobrinik D. (2000). J. Biol. Chem., 275, 30317-30325.
7. Chiarle R, Fan Y, Piva R, Boggino H, Skolnik J, Novero D, Palestro G, De Wolf-Peeters C, Chilosi M, Pagano M and Inghirami G. (2002). Am. J. Pathol., 160, 1457-1466.
8. Clurman BE, Sheaff RJ, Thress K, Groudine M and Roberts JM. (1996). Genes Dev., 10, 1979-1990.
9. Coats S, Whyte P, Fero ML, Lacy S, Chung G, Randel E, Firpo E and Roberts JM. (1999). Curr. Biol., 9, 163-173.
10. Deluca A, Maclachlan TK, Bagella L, Dean C, Howard CM, Claudio PP, Baldi A, Khalili K and Giordano A. (1997). J. Biol. Chem., 272, 20971-20974.
11. DeSalle LM and Pagano M. (2001). FEBS Lett., 490, 179-189.
12. Garriga J, Limon A, Mayol X, Rane SG, Albrecht JH, Reddy EP, Andrés V and Graña X. (1998). Biochem. J., 333, 645-654.
13. Garriga J, Mayol X and Graña X. (1996). Biochem. J., 319, 293-298.
14. Graña X, Garriga J and Mayol X. (1998). Oncogene, 17, 3365-3383.
15. Graña X and Reddy EP. (1995). Oncogene, 11, 211-219.
16. Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J and Krek W. (2001). Proc. Natl. Acad. Sci. USA, 98, 5043-5048.
17. Hansen K, Farkas T, Lukas J, Holm K, Ronnstrand L and Bartek J. (2001). EMBO J., 20, 422-432.
18. Harper JW. (2001). Curr. Biol., 11, R431-R435.
19. Hershko D, Bornstein G, Ben-Izhak O, Carrano A, Pagano M, Krausz MM and Hershko A. (2001). Cancer, 91, 1745-1751.
20. Kiess M, Gill RM and Hamel PA. (1995). Cell Growth Differ., 6, 1287-1298.
21. Krek W. (1998). Curr. Opin. Genet. Dev., 8, 36-42.
22. Lacy S and Whyte P. (1997). Oncogene, 14, 2395-2406.
23. Latres E, Chiarle R, Schulman BA, Pavletich NP, Pellicer A, Inghirami G and Pagano M. (2001). Proc. Natl. Acad. Sci. USA, 98, 2515-2520.
24. Lim MS, Adamson A, Lin Z, Perez-Ordonez B, Jordan RC, Tripp S, Perkins SL and Elenitoba-Johnson KS. (2002). Blood, 100, 2950-2956.
25. Lu L, Schulz H and Wolf DA. (2002). BMC Cell Biol., 3, 22.
26. Masuda TA, Inoue H, Sonoda H, Mine S, Yoshikawa Y, Nakayama K and Mori M. (2002). Cancer Res., 62, 3819-3825.
27. Mayol X, Garriga J and Graña X. (1995). Oncogene, 11, 801-808.
28. Mayol X, Garriga J and Graña X. (1996). Oncogene, 13, 237-246.
29. Mayol X and Graña X. (1998). Front. Biosci., 3, 11-24.
30. Mulligan G and Jacks T. (1998). Trends Genet., 14, 223-229.
31. Parreño M, Garriga J, Limon A, Albrecht J and Graña X. (2001). Oncogene, 20, 4793-4806.
32. Parreño M, Garriga J, Limon A, Mayol X, Beck Jr GR, Moran E and Graña X. (2000). J. Virol., 74, 3166-3176.
33. Penin RM, Fernandez-Figueras MT, Puig L, Rex J, Ferrandiz C and Ariza A. (2002). Mod. Pathol., 15, 1227-1235.
34. Prince AM, May JS, Burton GR, Lyle RE and McGehee Jr RE. (2002). Biochem. Biophys. Res. Commun., 290(3), 1066-1071.
35. Richon VM, Lyle RE and McGehee Jr RE. (1997). J. Biol. Chem., 272, 10117-10124.
36. Signoretti S, Di Marcotullio L, Richardson A, Ramaswamy S, Isaac B, Rue M, Monti F, Loda M and Pagano M. (2002). J. Clin. Invest., 110, 633-641.
37. Smith EJ, Leone G and Nevins JR. (1998). Cell Growth Differ., 9, 297-303.
38. Sutterluty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Muller U and Krek W. (1999). Nat. Cell Biol., 1, 207-214.
39. Tedesco D, Lukas J and Reed SI. (2002). Genes Dev., 16, 2946-2957.
40. Woo MS, Sanchez I and Dynlacht BD. (1997). Mol. Cell. Biol., 17, 3566-3579.
41. Yang G, Ayala G, Marzo AD, Tian W, Frolov A, Wheeler TM, Thompson TC and Harper JW. (2002). Clin. Cancer Res., 8, 3419-3426.
42. Yew PR. (2001). J. Cell Physiol., 187, 1-10.
43. Zalvide J, Stubdal H and DeCaprio JA. (1998). Mol. Cell. Biol., 18, 1408-1415.